A5038391320- Liver Disease Diagnosis and Treatment
- Liver Disease and Transplantation
- Prostate Cancer Diagnosis and Treatment
- Hepatocellular Carcinoma Treatment and Prognosis
- Statistical Methods in Clinical Trials
- Gallbladder and Bile Duct Disorders
- Alcohol Consumption and Health Effects
- Urologic and reproductive health conditions
- Pediatric Hepatobiliary Diseases and Treatments
- Bladder and Urothelial Cancer Treatments
- Health Systems, Economic Evaluations, Quality of Life
- Medical Malpractice and Liability Issues
- Liver Diseases and Immunity
- Music Therapy and Health
- Genital Health and Disease
- Dental Research and COVID-19
- Prostate Cancer Treatment and Research
- Urological Disorders and Treatments
- Hepatitis C virus research
- Urinary and Genital Oncology Studies
- Diverse Music Education Insights
- Biliary and Gastrointestinal Fistulas
- Eicosanoids and Hypertension Pharmacology
- Inhalation and Respiratory Drug Delivery
- Neuroscience and Music Perception
University of Padua
2022-2024
Gastroenterology Hospital "Saverio de Bellis"
2023
ERN GUARD-Heart
2023
San Raffaele University of Rome
1997
Liver transplantation (LT) has significantly transformed the prognosis of patients with end-stage liver disease and hepatocellular carcinoma (HCC). The traditional epidemiology diseases undergone a remarkable shift in indications for LT, marked by decline viral hepatitis an increase metabolic dysfunction-associated steatotic (MASLD), along expanded HCC. Recent advancements surgical techniques, organ preservation post-transplant patients’ management have opened new possibilities LT....
Hepatocellular carcinoma (HCC) in patients with decompensated cirrhosis presents significant treatment challenges due to the impaired liver function, altered pharmacokinetics, and systemic inflammation associated advanced disease. This review explores complexities of managing HCC this high-risk population, focusing on pharmacological considerations impact drug metabolism, efficacy, adverse effects. Studies indicate that drugs metabolized by liver, such as tyrosine kinase inhibitors (TKIs)...
Background and Aims: HCC can increase the risk of nonneoplastic PVT in cirrhosis. However, natural history its prognostic role patients are unknown. Approach Results: Consecutive with cirrhosis undergoing laparoscopic ablation were retrospectively evaluated followed up to 36 months. characteristics evolution reviewed. was categorized according lumen occupancy (≤50%, >50% <100%, = 100%) extension other veins. The thrombosis considered at 1 year from diagnosis. Variables associated...
The aim of this study was to evaluate the direct action IL-2 on recurrent superficial transitional bladder carcinoma and effect recurrence rate. 27 patients were submitted neoadjuvant treatment by intra-vesical instillation recombinant transurethral resection. We did not observe any neoplasms but rate less than expected one. It is possible that with may promote immuno-prophilaxis.
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)
Objectives. To analyse the relation between results of Aging Males' Symptoms (AMS) questionnaire for aging males, and quality life (QOL) SF-12 cardiovascular risk factors.Methods. 1,927 men aged 55–85 years were interviewed by 56 general practitioners. During interview asked to fill in AMS scale QOL SF-12.Results. Of 1,806 filled correctly questionnaire. The mean mental index was respectively 55.9 with a total score indicating no impairment, 50.9 mild, 42.8 moderate, 32.8 severe impairment....